0 Comments
0 Shares
496 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Global Altretamine Market to Reach USD 210 Million by 2034, Driven by Rising Ovarian Cancer Cases and Advancements in Oncology TherapiesAccording to new market intelligence from Intel Market Research, the global Altretamine market was valued at USD 120 million in 2024, with projections indicating steady growth to USD 210 million by 2034 at a CAGR of 5.8% during the forecast period (2026-2034). This expansion reflects increasing adoption in oncology treatment protocols, particularly for platinum-resistant ovarian cancer cases,...0 Comments 0 Shares 863 Views 0 Reviews
-
HER2+ Gastric Cancer Market Advances with Growing Focus on Biomarker-Driven Therapies and Precision Oncology InnovationsAccording to the latest report published by Data Bridge Market Research, the HER2+ Gastric Cancer Market The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44% A large scale HER2+ Gastric Cancer Market research reports...0 Comments 0 Shares 471 Views 0 Reviews
-
Mantle Cell Lymphoma Therapeutics Market to Reach USD 2.78 Billion by 2034, Driven by Advances in Targeted Therapies and CAR-T InnovationsAccording to a new report from Intel Market Research, the global Mantle Cell Lymphoma Therapeutics market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.78 billion by 2034, growing at a steady CAGR of 7.8% during the forecast period (2026–2034). This expansion reflects growing clinical adoption of novel targeted therapies and increasing healthcare investments in...0 Comments 0 Shares 2K Views 0 Reviews